SCHEMBL21751352

SCHEMBL21751352

O=c1c(Cc2ccco2)nc2c(Cc3ccccc3)[nH]c(-c3ccc(Cl)c(O)c3)cn1-2

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRAF P15056 1/20 0.34
▸ ADORA2A P29274 6/20 0.34
▸ ADORA2B P29275 6/20 0.34
▸ RORC P51449 1/20 0.33
▸ ARF6 P62330 2/20 0.33
▸ ALDH1A1 P00352 5/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ TSHR P16473 3/20 0.32
▸ USP2 O75604 2/20 0.32
▸ POLB P06746 2/20 0.32
▸ MAPT P10636 2/20 0.32
▸ CASP1 P29466 2/20 0.32
▸ BLM P54132 2/20 0.32
▸ CASP7 P55210 2/20 0.32
▸ NPSR1 Q6W5P4 2/20 0.32
▸ HSD17B10 Q99714 2/20 0.32
▸ LMNA P02545 2/20 0.32
▸ PKM P14618 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25760371 0.91 ADORA2B (0.37) ADORA2AADORA2BRORCALDH1A1KMT2A
SCHEMBL28888591 0.88 PSD (0.38) ADORA2AADORA2BALDH1A1KMT2ATSHR
SCHEMBL5560844 0.88 ALDH1A1 (0.37) ADORA2AADORA2BALDH1A1KMT2ATSHR
SCHEMBL30110483 0.88 ALDH1A1 (0.38) ADORA2AADORA2BALDH1A1KMT2ATSHR
SCHEMBL19810232 0.88 ALDH1A1 (0.38) ADORA2AADORA2BALDH1A1KMT2ATSHR
SCHEMBL30800156 0.88 ADORA2B (0.35) ADORA2AADORA2BALDH1A1KMT2ATSHR
SCHEMBL19810293 0.88 ADORA2B (0.35) ADORA2AADORA2BALDH1A1KMT2ATSHR
SCHEMBL19810310 0.87 ADORA2B (0.38) ADORA2AADORA2BALDH1A1KMT2ATSHR
SCHEMBL21751453 0.87 ADORA2A (0.33) ADORA2AADORA2BRORCARF6ALDH1A1
SCHEMBL21751303 0.87 ADORA2A (0.33) ADORA2AADORA2BRORCALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3981839-B1 COELENTERAZINE ANALOGS FOR USE IN LUCIFERASE-BASED ASSAYS PROMEGA CORP (US) 2025-08-20 — — EP disclosed
US-20240059697-A1 COELENTERAZINE ANALOGUES PROMEGA CORPORATION 2024-02-22 — — US disclosed
US-11691976-B2 Coelenterazine analogues PROMEGA CORPORATION (US) 2023-07-04 — — US disclosed
US-11691976-B2 Coelenterazine analogues PROMEGA CORPORATION (US) 2023-07-04 — — US disclosed
US-11691976-B2 Coelenterazine analogues PROMEGA CORPORATION (US) 2023-07-04 — — US disclosed
EP-3841173-A1 COELENTERAZINE ANALOGUES Promega Corporation (US) 2021-06-30 — — EP disclosed
WO-2020041579-A1 COELENTERAZINE ANALOGUES PROMEGA CORPORATION (US) 2020-02-27 — — WO disclosed
US-20200062766-A1 COELENTERAZINE ANALOGUES PROMEGA CORPORATION 2020-02-27 — — US disclosed
US-20200062766-A1 COELENTERAZINE ANALOGUES PROMEGA CORPORATION 2020-02-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200062766-A1 COELENTERAZINE ANALOGUES GLB1, SI, TCF7L2 BRAF 4209/4885ADORA2A 1970/4885ADORA2B 3105/4885
US-11691976-B2 Coelenterazine analogues GLB1, SI, TCF7L2 BRAF 4209/4885ADORA2A 1970/4885ADORA2B 3105/4885
US-20240059697-A1 COELENTERAZINE ANALOGUES GLB1, SI, TCF7L2 BRAF 4209/4885ADORA2A 1970/4885ADORA2B 3105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback